Thank you to Sasha Latypova for this thread.
Given the ongoing challenges that breast cancer poses in our society, what are the critical areas of research that the Department of Defense will be targeting with the $120 million in funding BCRP received in fiscal year 2014? Answer: The Department of Defense Breast Cancer Research Program, BCRP, has played a major role in the significant progress that has been made in the breast cancer field since 1992. --Breast Cancer Research ProgramBreast Cancer Research Program.
There were two ways to explain the increase:
1) Mammography detected cancers that would never have manifested (overdiagnosis). 2) Mammography itself created cancers because of X-rays.
The second explanation seemed excluded. Why? Because a commission of experts supervised by the U.S. military had evaluated that the risk associated with the radiation dose used for a mammogram was harmless. There is no data to support this claim; on the contrary.
The claim was supported by absurd arguments, such as the fact that the dose received during a one-second mammogram was the same as that received from the natural surroundings over 7 weeks, in an unprecedented propaganda campaign.
Breast Cancer Mammogram: How Does a Mammogram Work?
In reality, the cancer risks associated with the medical use of X-rays had been identified as early as the late 1960s by John Gofman, who was in charge of studying the biological effects of radiation at the U.S. Atomic Energy Commission.
His assessment was not acceptable to the army (which oversaw the implementation of civilian nuclear power, as it was a project on DURC), so they cut his funding and pushed him out. Instead, the AEC selected compliant experts who largely minimized the risk of these radiations.
Later, in 1995, after gathering substantial evidence, Gofman published a book, Preventing Breast Cancer, 1996, on the risk of radiation and breast cancer, which achieved some success but was met with complete silence from medical and scientific journals, except for negative reviews.
Gofman's scientific articles on this subject, despite his having over 100 publications to his name, were censored. This was the first indication that publications on topics related to dual-use research of concern had to receive the imprimatur of the US Department of Defense.
Towards the late 1990s, information emerged that should have served as a warning: mammography screening had not reduced breast cancer mortality in Sweden.
These initial results were confirmed in all countries: although breast cancer mortality had been reduced thanks to therapeutic advances, screening played no role in this reduction. "Impact of Screening Mammography on Breast Cancer Mortality," Archie Bleyer, Cornelia Baines, Anthony B. Miller, Int. Journal of Cancer, April 15, 2016.
It is amazing how often we find the influence of the Department of Defense in almost every conventional medical treatment.
David Gorski, a surgeon conducting cell biology research on breast cancer, is best known for opposing medical "disinformation" and promoting pro-vaccine propaganda. Many have suspected him of being a stooge for Big Pharma.
However, if you look at his funding, this is not the case. Gorski is funded by the Department of Defense. Since the NIAID, formed in 1955, became an appendage of the DoD, vaccines and the overdiagnosis hypothesis of breast cancer have become major concerns for the DoD.
Thanks to Daniel Corcos.
